Danrong Ye

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Identification of RPL4 as a biomarker associated with disulfidptosis and arachidonic acid metabolism in breast cancer.

Identification of RPL4 as a biomarker associated with disulfidptosis and arachidonic acid metabolism in breast cancer.

Journal: Discover oncology
Published: October 28, 2025

Corrigendum to "Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages" [J. Adv. Res. 69 (2025) 125-138].

Corrigendum to "Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages" [J. Adv. Res. 69 (2025) 125-138].

Journal: Journal of advanced research
Published: May 11, 2025

An integrated analysis of scRNA-seq and RNA-seq data revealed metastasis-related regulators as prognostic indicators in lung adenocarcinoma.

An integrated analysis of scRNA-seq and RNA-seq data revealed metastasis-related regulators as prognostic indicators in lung adenocarcinoma.

Journal: Journal of thoracic disease
Published: March 06, 2025

High Sugar Induced RCC2 Lactylation Drives Breast Cancer Tumorigenicity Through Upregulating MAD2L1.

High Sugar Induced RCC2 Lactylation Drives Breast Cancer Tumorigenicity Through Upregulating MAD2L1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 23, 2024

DLAT promotes triple-negative breast cancer progression via YAP1 activation.

DLAT promotes triple-negative breast cancer progression via YAP1 activation.

Journal: Cancer biology & therapy
Published: October 26, 2024

NASP Promotes Triple-negative Breast Cancer Progression and Metastasis by Stabilizing YAP in a USP15-Dependent Way.

NASP Promotes Triple-negative Breast Cancer Progression and Metastasis by Stabilizing YAP in a USP15-Dependent Way.

Journal: International journal of biological sciences
Published: June 09, 2024

ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.

ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.

Journal: Cell death & disease
Published: January 16, 2024

Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages.

Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages.

Journal: Journal of advanced research
Published: January 11, 2024

K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.

K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.

Journal: Cancer letters
Published: October 15, 2023

LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated β-catenin mRNA nuclear exportation.

LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated β-catenin mRNA nuclear exportation.

Journal: Environmental toxicology
Published: July 13, 2023

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer.

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer.

Journal: Frontiers in oncology
Published: February 15, 2023

DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.

DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.

Journal: Cell death & disease
Published: August 14, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026